Company Performance Metrics
- Xiaoming Gao: Founder & Chairman
HTBT is an enterprise dedicated to the introduction and research and development of diabetes series products and technologies, the construction of industrial clusters of protein oral drug delivery platforms, and the provision of full-course management services for diabetic patients. With flagship goods such oral insulin capsules, recombinant human
insulin, insulin analogs, and GLP-1, HTBT aims to establish itself as a credible and reliable biopharmaceutical company and a global biopharmaceutical product R&D and production base (GLP-1 receptor agonists).
